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Volume 58, Number 2 Abstracts 559wounds were managed with local wound care. Only one plantar wound
resulted in a major limb amputation.
Conclusion: Primary STSG was associated with successful healing in
the majority of plantar and nonplantar chronic wounds of the lower
extremity, even in patients with diabetes and attendant neuropathy.
Ex Vivo Renal Artery Reconstruction Is the Treatment Of Choice for
Complex Renal Artery Pathology
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Objectives: Evaluate long-term outcome of renal revascularization
using ex vivo renal artery reconstruction for complex renal artery pathology.
Methods: From 1987-2012, 23 patients (17 women; mean age, 45)
with complex renal artery lesions underwent open renal revascularizationusing
ex vivo technique. Underlying disease included ﬁbromuscular dysplasia with
aneurysm (11), atherosclerotic aneurysm (6), Takayasu arteritis (3), other
(3). Outcomes analyzed included primary, primary assisted and secondary
patency rates, antihypertensivemedication requirements, renal function/pres-
ervation, and mortality. Late graft patency, renal size and cortical thickness
were analyzed by serial renal duplex ultrasound examinations.
Results: Twenty-four kidneys in 23 patients were revascularized
using ex vivo renal artery reconstructive techniques. Perioperative compli-
cations were limited to two patients requiring reoperation for bleeding.
Renal function did not change and there were no in-hospital deaths.
Over mean follow-up of 44 months, a single bypass graft occluded
requiring a redo bypass, which was performed with renal preservation.
Primary, primary assisted and secondary patency rates were 94%% at 1
and 5 years. Compared to preoperative values, systolic/diastolic blood
pressure and the number of antihypertensive medications were reduced
(P < .05) in the 18 patients with hypertension. Late renal function was
preserved as measured by no change in both serum creatinine and
eGFR compared to preintervention values (P ¼ .25 and P ¼ .35, respec-
tively). In addition, there was no difference in treated kidney size or renal
cortical thickness on follow-up compared to preoperative measurements
(P ¼ .15 and P ¼ .62, respectively). No patient required dialysis. There
were 3 late deaths, none related to the renal procedure, providing 1 and
5-year actuarial survival of 94% and 85%, respectively.
Conclusions: Ex vivo renal artery reconstruction for complex renal
artery pathology confers a beneﬁt in blood pressure, while preserving renal
mass and function. This technique should be considered the treatment of
choice for complex renal artery pathology.
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Objectives: Most studies recommend repair of RAA > 2 cm diameter
in asymptomatic patients, but other studies have shown that RAA > 2 cm
remain clinically silent over a number of years. We hypothesized that rupture
and death in patients with asymptomatic RAA is low, and that current recom-
mendations for RAA treatment at 2 cm may be too aggressive.
Methods: Retrospective review of all RAA treated at a tertiary care
medical center from 2002-2012.
Results: Fifty-nine RAA were identiﬁed in 40 patients (mean age, 62;
M:F, 17:23); 32 were saccular, 7 fusiform, and 5 bilobed. Thirty-seven
aneurysms were asymptomatic (ARAA), with the rest being identiﬁed
during workup for difﬁcult-to-control hypertension (n ¼ 11), hematuria
(n ¼ 5), or ﬂank pain (n ¼ 3). Aneurysm location included the main renal
artery bifurcation (n ¼ 36), main trunk (n ¼ 8), primary branch (n ¼ 6),
pole artery (n ¼ 4), and secondary branch (n ¼ 1). Ten ARAA were oper-
ated on (mean RAA diameter, 2.4 6 .1 cm; range, 2-3 cm), with the
remaining 27 ARAA being managed conservatively (mean RAA diameter,
1.4 6 0.1 cm; range, 0.6-2.6 cm). Operative management of ARAA
included resection and patch angioplasty (n ¼ 8), resection with end-to-
end anastomosis (n ¼ 1), resection with patch and reimplantation (n ¼ 1)
and plication (n ¼ 1). Mean ARAA patient hospital LOS ¼ 5 days, with
a 0% morbidity and mortality rate at 12 months’ follow-up. Non-op
ARRA patients were followed for up to 14 years (mean, 3 years), with no
rupture and 0% mortality. Mean RAA growth rate of patients with multiple
imaging studies was 0.7 6 0.2 mm/yr. No ARAA > 2 cm managed non-
operatively ruptured (mean follow-up, 46 months).
Conclusions: The rate of aneurysm rupture and death in our
untreated RAA patients is zero, the growth rate is 0.7 6 0.2 mm/yr, and
RAA > 2 cm remained clinically silent for more than 3 years. We may
currently be too aggressive in treating asymptomatic RAA.Vascular Reconstruction During Major Oncologic Pancreatic
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Objectives: There is growing evidence that major vascular reconstruc-
tion performed during pancreaticoduodenectomy for malignancy may
increase local resectability without increasing morbidity or mortality. The
purpose of this study was to evaluate our experience with vascular recon-
structions during major pancreatic resections.
Methods: We performed an IRB approved review of patients with
planned and unplanned vascular surgery involvement during major pancre-
atic resections over an 8-year period. We analyzed patient demographics,
operative techniques, reconstruction patency, and early and late morbidity
and mortality.
Results: Forty-four patients were included in the study. Eighteen
(41%) cases were unplanned intraoperative consults, and 7 cases only
involved vascular assistance with dissection without reconstruction.
Average age of the patients was 64, median operative blood loss was
1.5 liters, and mean operative time was 7.5 hours. Of the 37 patients
who underwent vascular reconstruction, 31 (84%) involved portal or
superior mesenteric vein, 5 involved the superior mesenteric artery, 3
involved hepatic artery and one involved aortic repair. The majority of
reconstructions were either primary repair (29%) or superﬁcial femoral
vein graft (32%). Sixty six percent of patients had patent vascular recon-
structions on last follow up (mean f/u, 50 weeks). Perioperative mortality
was 4%. Median survival for all patients was 37.6 months. Patients with
adenocarcinoma (Fig) had a signiﬁcantly decreased survival compared to
other pathologies (16 vs 43.6 months; P ¼ .015), although still higher
than mean historical survival rates of patients with unresectable pancreatic
adenocarcinoma (3-9 months). Postoperative complications related to
vascular procedure occurred in 7 (16%) patients. Preoperatively planned
vascular involvement showed a trend to improved short-term mortality
(11% vs 0%; P ¼ .08).
Conclusions: Vascular reconstruction during major pancreatic resec-
tions provides good patency with acceptable vascular-related morbidity,
and can be considered as an option to increase local resectability and extend
survival. Preoperative vascular planning should be considered.Survey of the Initial Cohort of Graduating Integrated 0+5 Residents
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Objectives: The ﬁrst two integrated vascular residents in the United
States graduated in 2012, and in 2013 eleven more will enter the job
market. The purpose of this study was to compare the job search experi-
ences of the ﬁrst cohort of 0+5 graduates to their counterparts completing
5+2 fellowship programs.
Methods: An anonymous, web-based, 15-question survey was sent to
all graduating integrated residents in 2013, as well as the corresponding
5+2 graduating fellows within the same institution. Survey response was
nearly 70%.
Results: Survey responses are summarized below in the Table. Overall
there was not a signiﬁcant difference between the training cohorts for open
